Skip to content
lifestyle.wordsjournal.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Humacyte, Inc
Humacyte Announces Lancet Digital Health Publication of V007 Phase 3 Hemodialysis Access Trial Results
August 19, 2026
Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”
August 18, 2026
Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
Humacyte To Announce 2026 Second Quarter Financial Results and Provide Business Update on August 12, 2026
August 7, 2026
Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting
July 27, 2026
Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026
Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer
May 12, 2026
Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026
May 8, 2026
Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026
April 27, 2026
Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®
April 24, 2026
1
2
Next Page
→